This announcement is a separate document:
北京德恒（成都）律师事务所关于成都欧林生物科技股份有限公司2023年限制性股票激励计划之调整回购价格及授予价格、回购注销及作废部分限制性股票的法律意见
Legal opinion of Beijing Deheng (Chengdu) Law Firm on the adjustment of the repurchase price and grant price, repurchase cancellation, and abolition of some restricted stocks in the 2023 restricted stock incentive plan of Chengdu Olin Biotechnology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.